FDA approves launch of "six-in-one" children's vaccine Vaxelis

recently, Sanofi and Mersadon (MSD) jointly announced thatfda(http://approvethe launch of vaxelis, a "six-in-one" children's vaccine jointly developed by the two companiesVaxelis can simultaneously prevent invasive diseases caused by diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type BIt is suitable for children between 6 weeks and 4 years of ageAbout Vaxelis
Vaxelis, developed by Mercadoand and Sanofi, Sanofi will provide antigens for diphtheria, tetanus, pertussis and poliomyelitis, while Mercadowill will provide antigens for hepatitis B and Haemophilus influenzae type BChildren need to be vaccinated 3 times before the age of 5Vaxelis was approved in the EU in 2016the "six-in-one" vaccine would make it easier for children to get vaccinatedsanofi and Mercado,plans to expand Production in Vaxelis, build stocks that will continue to meet the needs of U.Schildren, and bring the vaccine to children in need by 2020